WHO ICTRP trial
Randomized study of intensified CHOP plus Rituximab (R-CHOP given every 14 days…
EUCTR2007-001519-52-PT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-001519-52-PT |
|---|---|
| Public title | Randomized study of intensified CHOP plus Rituximab (R-CHOP given every 14 days: R-CHOP 14) versus CHOP plus Rituximab given every 21 days (R-CHOP 21) and randomized study of frontline-prophylatic Darbepoietin alpha treatment versus usual symptomatic treatment of anemia in non previously treated patients aged from 60 to 80 years, with CD20+ diffuse large B-cell lymphoma |
| Scientific title | Randomized study of intensified CHOP plus Rituximab (R-CHOP given every 14 days: R-CHOP 14) versus CHOP plus Rituximab given every 21 days (R-CHOP 21) and randomized study of frontline-prophylatic Darbepoietin alpha treatment versus usual symptomatic treatment of anemia in non previously treated… |
| Primary sponsor | Groupe d'Etudes des Lymphomes de l'Adult |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal |
| Conditions | Study of frontline-prophylatic darbepoetin alpha treatment versus usual symptomatic treatment of anemia in non previously treated patients aged 60 to 80 years, with CD20+ diffuse large B-cell lymphoma MedDRA version: 9.1 Level: HLT… |
| Interventions | Trade Name: Aranesp 150 mcg Pharmaceutical Form: Solution for injection INN or Proposed INN: darbepoetin alfa CAS Number: 11096-26-7 Other descriptive name: DARBEPOETIN ALFA Concentration unit: Bq/µg becquerel(s)/microgram Concentration… |
| Registration date | Sep 26, 2007 |
| Secondary IDs | LNH 03-6B |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: